Background Ovarian cancer is the sixth most common cancer among women. In addition to
diagnosis and staging, primary surgery is performed to achieve optimal cytoreduction …

Several gastrointestinal and gynecological malignancies have the potential to disseminate
and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has …

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the
United States and is the country's fifth most common cause of cancer mortality in women. A …

This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common
ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and …

PURPOSE In SOLO1, maintenance olaparib (300 mg twice daily) significantly improved
progression-free survival (PFS) for patients with newly diagnosed BRCA1-and/or BRCA2 …

Background Ovarian cancer is the seventh most common cancer among women and a
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …

Over the past 40years, the survival of patients with advanced ovarian cancer has greatly
improved due to the introduction of combination chemotherapy with platinum and paclitaxel …

OBJECTIVE: To examine the effect of hospital procedure volume and other prognostic
variables on overall survival outcome and likelihood of receiving standard recommended …

Ovarian cancer is the eighth most frequent cancer in women and is the most lethal
gynecologic malignancy worldwide. The majority of ovarian cancer patients are newly …

Objective To characterize the impact of hospital and physician ovarian cancer case volume
on survival for advanced-stage disease and investigate socio-demographic variables …